TheEdgeResearch
Home / Stocks / BOIRF

Boiron S.A. (BOIRF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$31.50 ▲ +0.00%
Market Cap
$546.9M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.22
52-Wk Range
30-31.9
CEO
Pascal Houdayer
Country
FR
Currency
USD

Boiron S.A. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Messimy, FR. The stock last traded at $31.50, up 0.00% on the session, giving a market capitalisation of $546.9M. On trailing twelve-month figures it carries a trailing P/E of 12.65, a net margin of 5.3%. Its beta of 0.22 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
12.65
Price / Sales
0.66
Price / Book
0.87
EV / EBITDA
5.30
Gross margin
72.2%
Operating margin
5.2%
Net margin
5.3%
Return on equity
—
Debt / equity
0.06
Current ratio
2.25
Dividend yield
7.2%
Payout ratio
89.5%
Company profile
Exchange
Other OTC
Employees
2,634
IPO date
1996-05-02
Headquarters
Messimy, FR
About Boiron S.A.

Boiron S.A. is a global pharmaceutical company specializing in the production and distribution of homeopathic remedies across France, Europe, North America, and other international markets. Its extensive product portfolio encompasses a range of non-prescription, proprietary, and well-known branded homeopathic treatments. Noteworthy branded offerings include Oscillococcinum, designed to alleviate flu-like symptoms such as fever, chills, headaches, and body aches; Stodal and Stodaline, formulated for cough relief; Arnigel, providing topical support for minor, closed-wound traumas; Camilia, a solution for infant teething discomfort; and Sédatif PC, aimed at managing anxiety, emotional distress, and mild sleep disturbances. Furthermore, its homeopathic range features Coryzalia for addressing cold symptoms and rhinitis; Homéoptic, which targets eye discomfort and irritation in both adults and children; and Homéovox, developed for vocal issues. Beyond its core homeopathic line, Boiron also supplies dietary supplements; Dermoplasmine products (stick, balm, and mousse) for dry skin and lips; Mag' Nuit, an aid for promoting sleep; Arnitrosium for joint pain management; Castor Equi Boiron ointment for cracked skin; and Storinyl syrup for cold symptoms. The company's diverse inventory extends to herbal remedies, exemplified by Canephron, which supports increased urine production and improved urinary tract function; moisturizing lotions for babies; and medical devices, such as COVID-19 self-testing kits and rapid antigen tests. Boiron distributes its extensive product catalog through a comprehensive network encompassing distribution centers, independent pharmacies, pharmacy chains, wholesale partners, grocery and drugstores, specialized health food outlets, and various online retail platforms. Established in 1932, Boiron S.A. maintains its corporate headquarters in Messimy, France.

More research on BOIRF
BOIRF technical analysis BOIRF TheEdge Score Compare against peers
Open full interactive analysis & DCF →